tiprankstipranks
Trending News
More News >
ReposiTrak (TRAK)
NYSE:TRAK

ReposiTrak (TRAK) AI Stock Analysis

Compare
142 Followers

Top Page

TRAK

ReposiTrak

(NYSE:TRAK)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
,
Outperform 72 (OpenAI - 5.2)
,
Outperform 72 (OpenAI - 5.2)
,
Outperform 72 (OpenAI - 5.2)
,
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
$9.00
▲(11.94% Upside)
Action:ReiteratedDate:03/21/26
The score is driven primarily by strong financial quality (high margins, profitable growth, and very low leverage) and a constructive earnings-call outlook with continued capital returns. These positives are tempered by notably weak technical momentum (oversold and below key moving averages) and a premium P/E that leaves less room for execution missteps; corporate events are a smaller, mildly positive factor.
Positive Factors
High Profitability & Margins
Sustained very high gross margins and strong net margins reflect a scalable SaaS cost structure and pricing power. Durable profitability supports operating leverage, funds ongoing product investment and shareholder returns, and cushions the business against cyclical revenue swings over the next 2–6 months.
Conservative Balance Sheet & Cash
Extremely low leverage and a sizable cash position provide long-term financial flexibility: supports buybacks/dividend policy, funds selective product/IP investment, and reduces refinancing risk. This balance-sheet conservatism preserves optionality for growth or strategic deals over the medium term.
Recurring Revenue, Network Effects & IP Moat
Near-complete conversion to recurring SaaS combined with a large Traceability Network and filings for Touchless Traceability patents create durable customer stickiness and competitive barriers. Network effects force supplier adoption and the IP/AI detect-and-correct capabilities strengthen long-term revenue predictability.
Negative Factors
High Supplier Data Error Rates
Very high supplier data error rates impose ongoing manual remediation and support costs, increasing the unit economics of onboarding. Over months, this structural burden can slow platform scale, raise per-customer service requirements, and press margins unless AI automation meaningfully reduces error remediation.
Slow Traceability Onboarding
A multi-year onboarding timeline limits the speed at which Traceability revenue can scale, making regulatory tailwinds harder to monetize quickly. Structural implementation complexity lengthens sales cycles and delays realization of network effects, constraining meaningful revenue contribution in the near-to-mid term.
Negative FCF Growth & Cash Conversion Variability
Although absolute cash balances are strong, a recent decline in free-cash-flow growth and moderation of cash conversion signal variability in earnings quality. If this trend continues, it could limit reinvestment, slow debt reduction or reduce the pace of shareholder returns despite a healthy headline cash position.

ReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)

ReposiTrak Business Overview & Revenue Model

Company DescriptionReposiTrak, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, Audit Management, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is headquartered in Murray, Utah.
How the Company Makes MoneyReposiTrak primarily makes money by selling subscription access to its cloud-based compliance and supply chain management platform. A core revenue stream is recurring SaaS fees tied to enabling and maintaining compliance workflows between retailers and their supplier networks (e.g., document collection/validation, audit and certification tracking, and ongoing monitoring). The company also generates revenue from onboarding/activation and service-related fees associated with connecting suppliers to retailer-required programs and maintaining those connections over time. Revenue is largely supported by network effects: when a large retailer adopts ReposiTrak to enforce compliance requirements, many suppliers must join the platform to continue doing business with that retailer, which can expand the paying user base. Specific partnership details and exact pricing terms: null.

ReposiTrak Key Performance Indicators (KPIs)

Any
Any
Revenue by Type
Revenue by Type
Chart Insights
Data provided by:The Fly

ReposiTrak Earnings Call Summary

Earnings Call Date:Feb 17, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 18, 2026
Earnings Call Sentiment Positive
The call emphasized durable progress: steady revenue growth (7% Q2, 8% YTD), meaningful margin expansion (income from operations +34% Q2, +31% YTD), strong balance sheet (≈$28.7M cash, zero bank debt), continued share repurchases, dividend increases, and strategic investment in patented Touchless Traceability and AI-powered detect-and-correct capabilities. Key challenges center on high supplier data error rates (50%–70%), slower-than-ideal supplier onboarding that limits near-term Traceability revenue (currently ~8%–10%), an anticipated permanent step-up in effective tax rate (~20%), and some SG&A pressures. On balance the company presented multiple material positives (recurring revenue conversion, profitability, cash returns, IP moat, RTN scale) that outweigh the operational and market headwinds.
Q2-2026 Updates
Positive Updates
Recurring Revenue Transformation
Since 2020 the company converted over $7.0M of one-time revenue to recurring SaaS, increasing recurring revenue from 62% of total revenue to over 98%.
Top-Line Growth
Q2 fiscal 2026 revenue increased 7% year-over-year from $5.5M to $5.9M; fiscal 2026 year-to-date revenue increased 8% from $10.9M to $11.8M.
Profitability Expansion
Income from operations rose 34% year-over-year to $1.8M (from $1.4M). GAAP net income for Q2 increased 9% to $1.7M (from $1.6M). GAAP net income to common shareholders rose 13% to $1.6M (from $1.5M).
Earnings Per Share Improvement
Q2 EPS was $0.09 basic and diluted; year-to-date EPS was $0.19 basic and $0.18 diluted — a 13% increase versus the comparable period last year.
Operating Expense Discipline
Total operating expenses for the quarter decreased 2% despite continued investment in RTN and product development; fiscal year-to-date operating expenses were essentially flat year-over-year ($8.1M vs $8.1M).
Balance Sheet Strength and Cash Generation
Net cash compounded annual growth rate of 16% since 2020; net cash grew from $13.7M in 2020 to almost $29M in 2025. Total cash was $28.7M at Dec 31, 2025 and the company reported zero bank debt.
Capital Return to Shareholders
Repurchased ~80k common shares in Q2 for $1.1M (avg $13.75); total repurchases since inception are 2.22M shares for $14.5M (avg $6.52). Approximately $6.7M remains under the $21M buyback authorization. Declared quarterly dividend of $0.02/share (third 10% increase since 2022).
Preferred Stock Retirement
Redeemed 70k preferred shares in Q2 for $750k; total preferred redeemed ~642k shares for $6.9M, with 196k preferred shares (≈$2.1M) remaining and a stated plan to redeem remaining shares by Dec 2026 at current cadence.
Product & IP Investment
Filed two patents (Touchless Traceability and data-identification/auto-correction method) adding to a portfolio of 9 U.S. patents; continued investment in AI and modernization of core stack with limited expected incremental cash spend.
Traceability Network Scale and Technical Advantage
ReposiTrak claims industry-leading ReposiTrak Traceability Network (RTN) with nearly 2M records and a growing queue to join. Company highlighted proprietary detect-and-correct AI (500+ detection algorithms, self-learning) that can auto-correct many supplier data errors, creating a competitive moat.
Negative Updates
High Supplier Data Error Rates
Supplier data error rates, especially among small suppliers, are estimated at 50%–70%, creating significant complexity and manual remediation burdens across the supply chain that slow Traceability onboarding and usability.
Slow Onboarding and Implementation Timeline
Management estimates it takes a full 2+ years to make an entire supplier base Traceability-ready; onboarding is taking longer than hoped and many suppliers require extensive support, which constrains rapid adoption.
Limited Current Revenue Contribution from Traceability
Traceability represents a small portion of revenue (management estimates between 8% and 10%), so the business unit's future growth is critical but currently underweight in the overall mix.
Short-Term Headwinds from IP Timing and AI Perception
Filing patents prior to initiating sales was noted as a short-term headwind. Additionally, market misconceptions surrounding AI could cause some potential customers to attempt in-house solutions, creating a modest near-term sales headwind.
Rising Effective Tax Rate
Company is at the end of net operating loss benefits; management expects a ~20% effective tax rate going forward, representing a headwind to after-tax earnings relative to prior periods with NOL benefits.
Expense Increases in SG&A Components
While total operating expenses fell, SG&A was up 5% in the quarter due to higher commissions, insurance premiums and employee benefit costs, pressuring operating leverage in those line items.
Macro Risk: Food Inflation and Margin Pressure
Management noted that food inflation, if not passable to consumers, could cause margin squeeze across customers (retailers/distributors) and potentially increase scrutiny of third-party costs, including their services.
Company Guidance
Management's guidance emphasized continued SaaS conversion, capital returns and disciplined spending: since 2020 they converted >$7M of one‑time revenue to recurring and grew recurring revenue from 62% to >98%, paid down >$6M of bank debt, cut annual operating expense from ~$19M to $16M and expanded net margin from 8% to north of 30%; near‑term financials showed Q2 revenue +7% to $5.9M, Q2 operating income +34% to $1.8M, Q2 GAAP net income $1.7M (EPS $0.09 on 18.2M basic / 19.1M diluted), FYTD revenue +8% to $11.8M and FYTD operating income +31% to $3.7M. They expect a ~20% effective tax rate going forward, no meaningful incremental cash OpEx or CapEx for AI/patent work, continued balance‑sheet strength (net cash up from $13.7M in 2020 to ~ $29M in 2025 with $28.7M cash and 0 bank debt), ongoing buybacks (Q2 repurchased ~80k shares for $1.1M; 2.22M total repurchased for $14.5M; ~$6.7M authorization remaining), preferred redemptions at ~$750k/quarter with ~196k shares (~$2.1M) left targeted to be retired by Dec 2026, a quarterly dividend of $0.02 (third consecutive 10% raise) and a goal to return ~50% of annual cash from operations to shareholders while preparing for FDA‑driven acceleration of Traceability onboarding (~18 months to the deadline by year‑end).

ReposiTrak Financial Statement Overview

Summary
High-quality fundamentals supported by strong profitability (very high gross margin and ~31% net margin), solid revenue growth, and a very conservative balance sheet (minimal leverage, sizable cash). Main offsets are recent variability in cash conversion and negative TTM free-cash-flow growth.
Income Statement
86
Very Positive
TRAK shows strong, improving profitability with very high gross margins (TTM (Trailing-Twelve-Months) ~85%) and healthy net margins (~31%). Revenue has grown steadily over the last several annual periods, with a sharp acceleration in TTM growth (reported ~158%), supporting operating leverage and solid earnings power. The main watch-out is some volatility in operating profitability versus the most recent annual period (EBITDA margin lower in TTM than FY2025), suggesting margin cadence can move around period to period.
Balance Sheet
93
Very Positive
The balance sheet is very conservatively positioned: debt is minimal (TTM debt-to-equity ~0.01) and equity is sizable relative to assets, indicating low financial risk and strong flexibility. Returns on equity are solid and improving (TTM ~14.5% vs ~9–12% in earlier years), consistent with a profitable model without meaningful leverage. A potential downside is that with such low leverage, growth may depend more on internal cash generation rather than balance-sheet-driven expansion.
Cash Flow
78
Positive
Cash generation is generally strong and high-quality: operating cash flow and free cash flow track net income closely (TTM free cash flow is ~1.0x net income), suggesting limited earnings distortion. However, free cash flow growth is negative in TTM (about -15%), and operating cash flow coverage of net income has moderated versus some prior years, pointing to near-term variability in cash conversion despite still-healthy absolute cash flow.
BreakdownTTMJun 2025Sep 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue23.50M22.61M20.45M19.10M18.05M21.01M
Gross Profit19.97M18.92M17.04M15.79M14.86M13.10M
EBITDA8.71M8.95M7.61M7.11M5.38M5.41M
Net Income7.27M6.98M5.96M5.59M4.00M4.12M
Balance Sheet
Total Assets56.31M55.33M51.60M50.58M49.32M55.05M
Cash, Cash Equivalents and Short-Term Investments28.71M28.57M25.15M23.99M21.46M24.07M
Total Debt403.84K509.97K545.10K747.11K2.97M6.70M
Total Liabilities6.59M5.81M4.74M4.70M6.42M9.91M
Stockholders Equity49.72M49.52M46.85M45.88M42.90M45.14M
Cash Flow
Free Cash Flow6.84M8.40M6.89M7.96M6.05M5.08M
Operating Cash Flow6.87M8.42M6.96M8.86M6.10M5.40M
Investing Cash Flow-18.06K169.00-100.71K-903.19K1.32M-318.87K
Financing Cash Flow-6.16M-5.01M-5.70M-5.43M-10.03M-1.36M

ReposiTrak Technical Analysis

Technical Analysis Sentiment
Negative
Last Price8.04
Price Trends
50DMA
9.72
Negative
100DMA
11.73
Negative
200DMA
14.60
Negative
Market Momentum
MACD
-0.53
Negative
RSI
33.02
Neutral
STOCH
20.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 8.04 is below the 20-day moving average (MA) of 8.37, below the 50-day MA of 9.72, and below the 200-day MA of 14.60, indicating a bearish trend. The MACD of -0.53 indicates Negative momentum. The RSI at 33.02 is Neutral, neither overbought nor oversold. The STOCH value of 20.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Risk Analysis

ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ReposiTrak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$146.36M33.5114.66%0.57%11.05%18.55%
66
Neutral
$345.51M-11.71-19.64%-6.23%28.57%
63
Neutral
$247.65M6.24-38.92%14.78%-19.17%308.81%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$256.35M13.24-2.93%0.25%92.10%
54
Neutral
$303.71M-6.33-25.34%-24.30%-181.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRAK
ReposiTrak
8.04
-12.42
-60.70%
EGHT
8X8
1.84
-0.40
-17.86%
MKTW
MarketWise
15.45
5.33
52.67%
ONTF
ON24
8.06
2.45
43.67%
SMRT
SmartRent
1.58
0.38
31.67%

ReposiTrak Corporate Events

Business Operations and StrategyPrivate Placements and Financing
ReposiTrak Subsidiary Extends $4 Million Note to SPAR
Positive
Mar 20, 2026

On March 16, 2026, PC Group, Inc., a subsidiary of ReposiTrak, Inc., extended a senior unsecured promissory note of up to $4 million to SPAR Marketing Force, Inc., structured as a $3 million initial advance and an additional $1 million tranche available from July 17, 2026, at an 8% annual interest rate with interest-only monthly payments until its March 16, 2029 maturity. The loan, guaranteed by SPAR Group, Inc., includes the issuance of 1 million SPAR Group common shares to PC Group at a deemed value of $0.80 per share, with anti-dilution and price-protection mechanisms and customary default provisions, underscoring a deeper strategic commercial relationship and giving ReposiTrak both credit exposure and equity-linked upside tied to SPAR’s performance.

If SPAR defaults, interest on the note rises to 12% and PC Group can accelerate repayment, highlighting a risk-managed structure that balances yield with equity participation for ReposiTrak. The anti-dilution and minimum value protections attached to the SPAR shares are designed to preserve the economic value of PC Group’s equity consideration over the life of the note, potentially strengthening ReposiTrak’s positioning and influence within the retail marketing services sector while providing SPAR with flexible growth capital.

The most recent analyst rating on (TRAK) stock is a Buy with a $9.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
ReposiTrak Strengthens Board With Return of Industry Veteran
Positive
Mar 17, 2026

On March 17, 2026, ReposiTrak announced that James R. Gillis, CEO of M&A advisory firm Gillis & Associates Inc., rejoined its board of directors effective March 13, 2026, bringing more than 35 years of experience in retail supply chain management, M&A and organizational growth. His background leading Source Interlink Companies Inc., serving on multiple corporate boards and advising private equity firms is expected to support ReposiTrak’s efforts to scale its network, accelerate innovation and enhance value for retail, wholesale and supplier stakeholders.

Company leaders highlighted that Gillis’ strategic and operational expertise has been instrumental to ReposiTrak’s progress in the past and will be key as it pursues its next phase of expansion. The appointment underscores the company’s focus on combining technology-driven supply chain transformation with stronger industry partnerships to deepen its market position in food traceability, regulatory compliance and retail supply chain solutions.

The most recent analyst rating on (TRAK) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
ReposiTrak posts strong Q2 growth and dividend hike
Positive
Feb 19, 2026

For the second fiscal quarter ended December 31, 2025, ReposiTrak reported a 7% revenue increase to $5.9 million and a 34% jump in operating income to $1.8 million, lifting operating margin to 31%. GAAP net income rose to $1.7 million, with net income to common shareholders up 13% to $1.6 million, or $0.09 per diluted share, while the company closed the quarter holding $28.7 million in cash and no bank debt.

ReposiTrak highlighted patent filings for its new Touchless Traceability solution, which augments its ReposiTrak Traceability Network to automate compliant data records at scale and aims to deepen its competitive moat. The company continued returning capital to investors in the quarter, redeeming preferred shares, repurchasing 79,927 common shares for about $1.1 million and delivering a third consecutive 10% dividend increase, underscoring confidence in its structural profitability and growth in demand for its traceability and compliance offerings.

The most recent analyst rating on (TRAK) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 21, 2026